Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
REVENUE
Sales	$ 323,125		$ 748,119
Cost of goods sold	233,684		596,613
Gross Profit	89,441		151,506
OPERATING EXPENSES
General and administrative expenses, $461,492, $650,325, $1,288,829 and $2,887,657 in stock-based compensation, respectively	3,919,618	4,451,545	12,332,728	14,348,375
Research and development, includes $170,066, $248,989, $473,593 and $248,989 in stock-based compensation, respectively	1,570,540	1,471,544	4,186,842	3,340,247
Sales and marketing $0, $0, $754,699, and $0 in stock-based compensation, respectively	(8,553)	150,056	911,988	252,562
Total operating expenses	5,418,605	6,073,145	17,431,558	17,941,184
NET LOSS FROM OPERATIONS	(5,392,164)	(6,073,145)	(17,280,052)	(17,941,184)
OTHER EXPENSE
Interest expense	(645,381)	(38,198)	(742,701)	(74,587)
Interest income	10,084	42,838	30,131	43,267
Other income			58,960
Loss on extinguishment of debt		(2,500,970)		(2,500,970)
Amortization of debt discount	(1,530,102)	(1,191,254)	(1,533,048)	(1,845,358)
Total other expense	(2,165,399)	(3,687,584)	(2,186,658)	(4,377,648)
Net loss before income taxes	(7,557,563)	(9,760,729)	(19,466,710)	(22,318,832)
Income tax provision
NET LOSS	$ (7,557,563)	$ (9,760,729)	$ (19,466,710)	$ (22,318,832)
Net loss per share - basic and diluted (in Dollars per share)	$ (5.27)	$ (28.08)	$ (18.01)	$ (73.08)
Weighted average number of shares outstanding during the period - basic and diluted (in Shares)	1,433,175	347,610	1,080,661	305,416